English
Visit booth 3201 at AACC 2019 to experience how automation helps solve the unique challenges of small-, mid- and high-volume laboratories
Anaheim, Calif., Aug. 1, 2019 — Beckman Coulter today announced that at the 71st Annual AACC conference it will showcase its clinical chemistry, immunoassay, hematology, urinalysis and microbiology solutions, configured in the booth to meet the specific needs of any sized laboratory. During the Scientific Meeting & Clinical Lab Expo, Beckman Coulter will demonstrate how laboratories of all sizes can elevate their performance and advance patient care through the power automation and clinical informatics.
“Around the globe, hospital laboratories face staffing and operational challenges. As a result, we see laboratory managers taking an integrated workflow approach and embracing automation to streamline laboratory operations. In the past, only high-volume laboratories were able to reap the benefits of automation. Now, because of solutions from Beckman Coulter, all laboratories — low-, mid- and high-volume — can access the power of automation to optimize their laboratory and improve efficiency,” said Julie Sawyer Montgomery, senior vice president at Beckman Coulter.
“Automation plays a critical role in addressing a myriad of challenges faced by laboratories. At the AACC conference, we will demonstrate a variety of scenarios designed to highlight how our solutions help laboratories improve analytical performance, increase operational efficiency and reduce manual work steps, freeing up valuable time for laboratorians to better partner with clinicians,” continued Sawyer Montgomery.
Beckman Coulter will demonstrate its robust portfolio of WorkflowConnect, WorkflowAdvanced, and WorkflowCommand automation solutions that are designed to meet the needs of small-, mid- and high-volume laboratories. Booth demonstrations will also include Beckman Coulter’s newest total laboratory automation solution, the DxA 50001 (which is coming soon to the U.S. market).
The DxA 5000 is designed to help laboratories significantly improve efficiency through a collection of patented innovations that:
• identify and address pre-analytical errors
• automate labor intensive and error prone laboratory workflow
• use true intelligent routing to prioritize STATs
• auto-verify and release normal results without delay
Sepsis panel discussion: Know sooner, act faster
Beckman Coulter is also hosting a sepsis diagnosis and treatment panel discussion, “A Race against Time — The Challenge of Sepsis for Clinicians and Laboratorians,” on Tuesday, Aug. 6, 2019, from 7-8:30 a.m. at the Hilton Anaheim, Pacific A/B Ballroom. This panel will be moderated by Jeannine Holden, M.D., chief medical officer and vice president, medical and scientific affairs, Beckman Coulter.
Sepsis is a life-threatening syndrome that affects approximately 30 million people worldwide2 every year and carries a 25-30% mortality rate. It is also costly to healthcare organizations, with more than $24 billion dollars spent on sepsis annually in the United States alone3.
“We are excited about this panel, which will feature clinician and laboratorian perspectives on the healthcare burden of sepsis, and the importance of speed and cooperation in its diagnosis and management,” said Sawyer Montgomery. “Beckman Coulter is committed to helping medical professionals with the education, innovation and solutions they need to better understand, diagnose and manage sepsis.”
For more information about the Early Sepsis Indicator and Beckman Coulter’s robust portfolio of sepsis diagnosis and management solutions, visit BeckmanCoulter.com/events.
“Around the globe, hospital laboratories face staffing and operational challenges. As a result, we see laboratory managers taking an integrated workflow approach and embracing automation to streamline laboratory operations. In the past, only high-volume laboratories were able to reap the benefits of automation. Now, because of solutions from Beckman Coulter, all laboratories — low-, mid- and high-volume — can access the power of automation to optimize their laboratory and improve efficiency,” said Julie Sawyer Montgomery, senior vice president at Beckman Coulter.
“Automation plays a critical role in addressing a myriad of challenges faced by laboratories. At the AACC conference, we will demonstrate a variety of scenarios designed to highlight how our solutions help laboratories improve analytical performance, increase operational efficiency and reduce manual work steps, freeing up valuable time for laboratorians to better partner with clinicians,” continued Sawyer Montgomery.
Beckman Coulter will demonstrate its robust portfolio of WorkflowConnect, WorkflowAdvanced, and WorkflowCommand automation solutions that are designed to meet the needs of small-, mid- and high-volume laboratories. Booth demonstrations will also include Beckman Coulter’s newest total laboratory automation solution, the DxA 50001 (which is coming soon to the U.S. market).
The DxA 5000 is designed to help laboratories significantly improve efficiency through a collection of patented innovations that:
• identify and address pre-analytical errors
• automate labor intensive and error prone laboratory workflow
• use true intelligent routing to prioritize STATs
• auto-verify and release normal results without delay
Sepsis panel discussion: Know sooner, act faster
Beckman Coulter is also hosting a sepsis diagnosis and treatment panel discussion, “A Race against Time — The Challenge of Sepsis for Clinicians and Laboratorians,” on Tuesday, Aug. 6, 2019, from 7-8:30 a.m. at the Hilton Anaheim, Pacific A/B Ballroom. This panel will be moderated by Jeannine Holden, M.D., chief medical officer and vice president, medical and scientific affairs, Beckman Coulter.
Sepsis is a life-threatening syndrome that affects approximately 30 million people worldwide2 every year and carries a 25-30% mortality rate. It is also costly to healthcare organizations, with more than $24 billion dollars spent on sepsis annually in the United States alone3.
“We are excited about this panel, which will feature clinician and laboratorian perspectives on the healthcare burden of sepsis, and the importance of speed and cooperation in its diagnosis and management,” said Sawyer Montgomery. “Beckman Coulter is committed to helping medical professionals with the education, innovation and solutions they need to better understand, diagnose and manage sepsis.”
For more information about the Early Sepsis Indicator and Beckman Coulter’s robust portfolio of sepsis diagnosis and management solutions, visit BeckmanCoulter.com/events.
